PDB Short entry for 1Q6P HEADER HYDROLASE 13-AUG-03 1Q6P TITLE THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH TITLE 2 COMPOUND 6 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN; COMPND 5 SYNONYM: PROTEIN-TYROSINE PHOSPHATASE 1B, PTP-1B; COMPND 6 EC: 3.1.3.48; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PTPN1 OR PTP1B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PFLAG-2 KEYWDS PHOSPHATASE, SECONDARY BINDING SITE, SELECTIVITY, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR G.SCAPIN,S.B.PATEL,J.W.BECKER,Q.WANG,C.DESPONTS,D.WADDLETON,K.SKOREY, AUTHOR 2 W.CROMLISH,C.BAYLY,M.THERIEN,J.Y.GAUTHIER,C.S.LI,C.K.LAU, AUTHOR 3 C.RAMACHANDRAN,B.P.KENNEDY,E.ASANTE-APPIAH REVDAT 5 16-AUG-23 1Q6P 1 REMARK SEQADV REVDAT 4 11-OCT-17 1Q6P 1 REMARK REVDAT 3 24-FEB-09 1Q6P 1 VERSN REVDAT 2 14-OCT-03 1Q6P 1 JRNL REVDAT 1 30-SEP-03 1Q6P 0 JRNL AUTH G.SCAPIN,S.B.PATEL,J.W.BECKER,Q.WANG,C.DESPONTS,D.WADDLETON, JRNL AUTH 2 K.SKOREY,W.CROMLISH,C.BAYLY,M.THERIEN,J.Y.GAUTHIER,C.S.LI, JRNL AUTH 3 C.K.LAU,C.RAMACHANDRAN,B.P.KENNEDY,E.ASANTE-APPIAH JRNL TITL THE STRUCTURAL BASIS FOR THE SELECTIVITY OF BENZOTRIAZOLE JRNL TITL 2 INHIBITORS OF PTP1B JRNL REF BIOCHEMISTRY V. 42 11451 2003 JRNL REFN ISSN 0006-2960 JRNL PMID 14516196 JRNL DOI 10.1021/BI035098J REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.1 REMARK 3 NUMBER OF REFLECTIONS : 46645 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.210 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.238 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2341 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 48584 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.38 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.30 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4167 REMARK 3 BIN R VALUE (WORKING SET) : 0.2740 REMARK 3 BIN FREE R VALUE : 0.3320 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 210 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4670 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 95 REMARK 3 SOLVENT ATOMS : 209 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 34.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.74700 REMARK 3 B22 (A**2) : 2.69600 REMARK 3 B33 (A**2) : -7.44300 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM SIGMAA (A) : 0.26 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.31 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.013 REMARK 3 BOND ANGLES (DEGREES) : 1.420 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.880 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.200 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.600 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.100 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.500 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : MASK REMARK 3 KSOL : 0.41 REMARK 3 BSOL : 52.70 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1Q6P COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-AUG-03. REMARK 100 THE DEPOSITION ID IS D_1000019984. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-AUG-99 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : X-GEN REMARK 200 DATA SCALING SOFTWARE : X-GEN REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 48690 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 7.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08300 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.41 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.30 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.38200 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNX REMARK 200 STARTING MODEL: PDB ENTRY 1Q6N REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 66.91 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.72 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, MGCL2, HEPES, PH 7.00, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 43.97250 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 69.61400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.02250 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 69.61400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 43.97250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.02250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 489 REMARK 465 ASP A 490 REMARK 465 TYR A 491 REMARK 465 LYS A 492 REMARK 465 ASP A 493 REMARK 465 ASP A 494 REMARK 465 ASP A 495 REMARK 465 ASP A 496 REMARK 465 ASP A 784 REMARK 465 SER A 785 REMARK 465 SER A 786 REMARK 465 VAL A 787 REMARK 465 GLN A 788 REMARK 465 ASP A 789 REMARK 465 GLN A 790 REMARK 465 TRP A 791 REMARK 465 LYS A 792 REMARK 465 GLU A 793 REMARK 465 LEU A 794 REMARK 465 SER A 795 REMARK 465 HIS A 796 REMARK 465 GLU A 797 REMARK 465 ASP A 798 REMARK 465 MET B 989 REMARK 465 ASP B 990 REMARK 465 TYR B 991 REMARK 465 LYS B 992 REMARK 465 ASP B 993 REMARK 465 ASP B 994 REMARK 465 ASP B 995 REMARK 465 ASP B 996 REMARK 465 ASP B 1284 REMARK 465 SER B 1285 REMARK 465 SER B 1286 REMARK 465 VAL B 1287 REMARK 465 GLN B 1288 REMARK 465 ASP B 1289 REMARK 465 GLN B 1290 REMARK 465 TRP B 1291 REMARK 465 LYS B 1292 REMARK 465 GLU B 1293 REMARK 465 LEU B 1294 REMARK 465 SER B 1295 REMARK 465 HIS B 1296 REMARK 465 GLU B 1297 REMARK 465 ASP B 1298 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 497 CG CD CE NZ REMARK 470 LEU A 498 CG CD1 CD2 REMARK 470 MET A 501 CG SD CE REMARK 470 LYS B 997 CG CD CE NZ REMARK 470 LEU B 998 CG CD1 CD2 REMARK 470 MET B1001 CG SD CE REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 563 -94.51 -42.97 REMARK 500 SER A 618 117.74 63.62 REMARK 500 LEU A 619 109.17 -54.69 REMARK 500 CYS A 621 140.68 -174.81 REMARK 500 LYS A 631 69.74 -119.46 REMARK 500 PHE A 682 14.49 59.67 REMARK 500 CYS A 715 -131.25 -139.03 REMARK 500 ILE A 719 -39.43 -132.27 REMARK 500 ILE A 761 113.33 74.99 REMARK 500 MET A 782 40.87 -84.54 REMARK 500 ASP B1063 -87.28 -43.39 REMARK 500 ASN B1111 -167.64 -117.84 REMARK 500 LEU B1119 70.51 -67.89 REMARK 500 LYS B1120 -164.45 -112.80 REMARK 500 CYS B1121 140.11 179.79 REMARK 500 GLN B1166 19.67 56.75 REMARK 500 PHE B1182 15.73 57.10 REMARK 500 CYS B1215 -134.66 -133.09 REMARK 500 ILE B1219 -39.28 -134.78 REMARK 500 ILE B1261 116.52 77.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 2001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 213 A 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 213 B 1301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1Q6J RELATED DB: PDB REMARK 900 SAME PROTEIN IN COMPLEX WITH [4-(2-(1H-1,2,3-BENZOTRIAZOL-1-YL)-3-{ REMARK 900 4-[DIFLUORO(PHOSPHONO)METHYL]PHENYL}-2-PHENYLPROPYL)PHENYL] REMARK 900 (DIFLUORO)METHYLPHOSPHONIC ACID REMARK 900 RELATED ID: 1Q6M RELATED DB: PDB REMARK 900 SAME PROTEIN IN COMPLEX WITH {[2-(1H-1,2,3-BENZOTRIAZOL-1-YL)-2-(3, REMARK 900 4-DIFLUOROPHENYL)PROPANE-1,3-DIYL]BIS[4,1- REMARK 900 PHENYLENE(DIFLUOROMETHYLENE)]}BISPHOSPHONIC ACID REMARK 900 RELATED ID: 1Q6N RELATED DB: PDB REMARK 900 SAME PROTEIN IN COMPLEX WITH [{4-[(4E)-2-(1,3-BENZOTHIAZOL-2-YL)-2- REMARK 900 (1H-1,2,3-BENZOTRIAZOL-1-YL)-5-PHENYLPENT-4-EN-1-YL]PHENYL} REMARK 900 (DIFLUORO)METHYL]PHOSPHONIC ACID REMARK 900 RELATED ID: 1Q6S RELATED DB: PDB REMARK 900 SAME PROTEIN IN COMPLEX WITH {6-[4-(2-(1H-1,2,3-BENZOTRIAZOL-1-YL)- REMARK 900 3-{4-[DIFLUORO(PHOSPHONO)METHYL]PHENYL}-2-PHENYLPROPYL)PHENYL]-2- REMARK 900 METHYLQUINOLIN-8-YL}PHOSPHONIC ACID REMARK 900 RELATED ID: 1Q6T RELATED DB: PDB REMARK 900 SAME PROTEIN IN COMPLEX WITH [6-[4-(2-(1H-1,2,3-BENZOTRIAZOL-1-YL)- REMARK 900 3-{4-[DIFLUORO(PHOSPHONO)METHYL]PHENYL}-2-PHENYLPROPYL)PHENYL]-2-(1- REMARK 900 METHOXY-3-METHYLBUTYL)QUINOLIN-8-YL]PHOSPHONIC ACID DBREF 1Q6P A 501 798 UNP P18031 PTN1_HUMAN 1 298 DBREF 1Q6P B 1001 1298 UNP P18031 PTN1_HUMAN 1 298 SEQADV 1Q6P MET A 489 UNP P18031 CLONING ARTIFACT SEQADV 1Q6P ASP A 490 UNP P18031 CLONING ARTIFACT SEQADV 1Q6P TYR A 491 UNP P18031 CLONING ARTIFACT SEQADV 1Q6P LYS A 492 UNP P18031 CLONING ARTIFACT SEQADV 1Q6P ASP A 493 UNP P18031 CLONING ARTIFACT SEQADV 1Q6P ASP A 494 UNP P18031 CLONING ARTIFACT SEQADV 1Q6P ASP A 495 UNP P18031 CLONING ARTIFACT SEQADV 1Q6P ASP A 496 UNP P18031 CLONING ARTIFACT SEQADV 1Q6P LYS A 497 UNP P18031 CLONING ARTIFACT SEQADV 1Q6P LEU A 498 UNP P18031 CLONING ARTIFACT SEQADV 1Q6P GLU A 499 UNP P18031 CLONING ARTIFACT SEQADV 1Q6P PHE A 500 UNP P18031 CLONING ARTIFACT SEQADV 1Q6P MET B 989 UNP P18031 CLONING ARTIFACT SEQADV 1Q6P ASP B 990 UNP P18031 CLONING ARTIFACT SEQADV 1Q6P TYR B 991 UNP P18031 CLONING ARTIFACT SEQADV 1Q6P LYS B 992 UNP P18031 CLONING ARTIFACT SEQADV 1Q6P ASP B 993 UNP P18031 CLONING ARTIFACT SEQADV 1Q6P ASP B 994 UNP P18031 CLONING ARTIFACT SEQADV 1Q6P ASP B 995 UNP P18031 CLONING ARTIFACT SEQADV 1Q6P ASP B 996 UNP P18031 CLONING ARTIFACT SEQADV 1Q6P LYS B 997 UNP P18031 CLONING ARTIFACT SEQADV 1Q6P LEU B 998 UNP P18031 CLONING ARTIFACT SEQADV 1Q6P GLU B 999 UNP P18031 CLONING ARTIFACT SEQADV 1Q6P PHE B 1000 UNP P18031 CLONING ARTIFACT SEQRES 1 A 310 MET ASP TYR LYS ASP ASP ASP ASP LYS LEU GLU PHE MET SEQRES 2 A 310 GLU MET GLU LYS GLU PHE GLU GLN ILE ASP LYS SER GLY SEQRES 3 A 310 SER TRP ALA ALA ILE TYR GLN ASP ILE ARG HIS GLU ALA SEQRES 4 A 310 SER ASP PHE PRO CYS ARG VAL ALA LYS LEU PRO LYS ASN SEQRES 5 A 310 LYS ASN ARG ASN ARG TYR ARG ASP VAL SER PRO PHE ASP SEQRES 6 A 310 HIS SER ARG ILE LYS LEU HIS GLN GLU ASP ASN ASP TYR SEQRES 7 A 310 ILE ASN ALA SER LEU ILE LYS MET GLU GLU ALA GLN ARG SEQRES 8 A 310 SER TYR ILE LEU THR GLN GLY PRO LEU PRO ASN THR CYS SEQRES 9 A 310 GLY HIS PHE TRP GLU MET VAL TRP GLU GLN LYS SER ARG SEQRES 10 A 310 GLY VAL VAL MET LEU ASN ARG VAL MET GLU LYS GLY SER SEQRES 11 A 310 LEU LYS CYS ALA GLN TYR TRP PRO GLN LYS GLU GLU LYS SEQRES 12 A 310 GLU MET ILE PHE GLU ASP THR ASN LEU LYS LEU THR LEU SEQRES 13 A 310 ILE SER GLU ASP ILE LYS SER TYR TYR THR VAL ARG GLN SEQRES 14 A 310 LEU GLU LEU GLU ASN LEU THR THR GLN GLU THR ARG GLU SEQRES 15 A 310 ILE LEU HIS PHE HIS TYR THR THR TRP PRO ASP PHE GLY SEQRES 16 A 310 VAL PRO GLU SER PRO ALA SER PHE LEU ASN PHE LEU PHE SEQRES 17 A 310 LYS VAL ARG GLU SER GLY SER LEU SER PRO GLU HIS GLY SEQRES 18 A 310 PRO VAL VAL VAL HIS CYS SER ALA GLY ILE GLY ARG SER SEQRES 19 A 310 GLY THR PHE CYS LEU ALA ASP THR CYS LEU LEU LEU MET SEQRES 20 A 310 ASP LYS ARG LYS ASP PRO SER SER VAL ASP ILE LYS LYS SEQRES 21 A 310 VAL LEU LEU GLU MET ARG LYS PHE ARG MET GLY LEU ILE SEQRES 22 A 310 GLN THR ALA ASP GLN LEU ARG PHE SER TYR LEU ALA VAL SEQRES 23 A 310 ILE GLU GLY ALA LYS PHE ILE MET GLY ASP SER SER VAL SEQRES 24 A 310 GLN ASP GLN TRP LYS GLU LEU SER HIS GLU ASP SEQRES 1 B 310 MET ASP TYR LYS ASP ASP ASP ASP LYS LEU GLU PHE MET SEQRES 2 B 310 GLU MET GLU LYS GLU PHE GLU GLN ILE ASP LYS SER GLY SEQRES 3 B 310 SER TRP ALA ALA ILE TYR GLN ASP ILE ARG HIS GLU ALA SEQRES 4 B 310 SER ASP PHE PRO CYS ARG VAL ALA LYS LEU PRO LYS ASN SEQRES 5 B 310 LYS ASN ARG ASN ARG TYR ARG ASP VAL SER PRO PHE ASP SEQRES 6 B 310 HIS SER ARG ILE LYS LEU HIS GLN GLU ASP ASN ASP TYR SEQRES 7 B 310 ILE ASN ALA SER LEU ILE LYS MET GLU GLU ALA GLN ARG SEQRES 8 B 310 SER TYR ILE LEU THR GLN GLY PRO LEU PRO ASN THR CYS SEQRES 9 B 310 GLY HIS PHE TRP GLU MET VAL TRP GLU GLN LYS SER ARG SEQRES 10 B 310 GLY VAL VAL MET LEU ASN ARG VAL MET GLU LYS GLY SER SEQRES 11 B 310 LEU LYS CYS ALA GLN TYR TRP PRO GLN LYS GLU GLU LYS SEQRES 12 B 310 GLU MET ILE PHE GLU ASP THR ASN LEU LYS LEU THR LEU SEQRES 13 B 310 ILE SER GLU ASP ILE LYS SER TYR TYR THR VAL ARG GLN SEQRES 14 B 310 LEU GLU LEU GLU ASN LEU THR THR GLN GLU THR ARG GLU SEQRES 15 B 310 ILE LEU HIS PHE HIS TYR THR THR TRP PRO ASP PHE GLY SEQRES 16 B 310 VAL PRO GLU SER PRO ALA SER PHE LEU ASN PHE LEU PHE SEQRES 17 B 310 LYS VAL ARG GLU SER GLY SER LEU SER PRO GLU HIS GLY SEQRES 18 B 310 PRO VAL VAL VAL HIS CYS SER ALA GLY ILE GLY ARG SER SEQRES 19 B 310 GLY THR PHE CYS LEU ALA ASP THR CYS LEU LEU LEU MET SEQRES 20 B 310 ASP LYS ARG LYS ASP PRO SER SER VAL ASP ILE LYS LYS SEQRES 21 B 310 VAL LEU LEU GLU MET ARG LYS PHE ARG MET GLY LEU ILE SEQRES 22 B 310 GLN THR ALA ASP GLN LEU ARG PHE SER TYR LEU ALA VAL SEQRES 23 B 310 ILE GLU GLY ALA LYS PHE ILE MET GLY ASP SER SER VAL SEQRES 24 B 310 GLN ASP GLN TRP LYS GLU LEU SER HIS GLU ASP HET CL A2001 1 HET 213 A 801 47 HET 213 B1301 47 HETNAM CL CHLORIDE ION HETNAM 213 4'-((2S)-2-(1H-1,2,3-BENZOTRIAZOL-1-YL)-3-{4- HETNAM 2 213 [DIFLUORO(PHOSPHONO)METHYL]PHENYL}-2-PHENYLPROPYL)-1, HETNAM 3 213 1'-BIPHENYL-3-YLPHOSPHONIC ACID FORMUL 3 CL CL 1- FORMUL 4 213 2(C34 H29 F2 N3 O6 P2) FORMUL 6 HOH *209(H2 O) HELIX 1 1 LEU A 498 GLY A 514 1 17 HELIX 2 2 SER A 515 ALA A 527 1 13 HELIX 3 3 LEU A 537 ASN A 544 5 8 HELIX 4 4 PHE A 552 HIS A 554 5 3 HELIX 5 5 THR A 591 GLN A 602 1 12 HELIX 6 6 SER A 687 SER A 701 1 15 HELIX 7 7 ILE A 719 ARG A 738 1 20 HELIX 8 8 ASP A 740 VAL A 744 5 5 HELIX 9 9 ASP A 745 LYS A 755 1 11 HELIX 10 10 THR A 763 MET A 782 1 20 HELIX 11 11 LYS B 997 SER B 1013 1 17 HELIX 12 12 SER B 1015 ALA B 1027 1 13 HELIX 13 13 CYS B 1032 LEU B 1037 1 6 HELIX 14 14 PRO B 1038 ASN B 1044 5 7 HELIX 15 15 THR B 1091 GLN B 1102 1 12 HELIX 16 16 SER B 1187 SER B 1201 1 15 HELIX 17 17 GLY B 1220 ARG B 1238 1 19 HELIX 18 18 ASP B 1240 VAL B 1244 5 5 HELIX 19 19 ASP B 1245 LYS B 1255 1 11 HELIX 20 20 THR B 1263 GLY B 1283 1 21 SHEET 1 A 9 ARG A 556 LYS A 558 0 SHEET 2 A 9 TYR A 566 MET A 574 -1 O ALA A 569 N ILE A 557 SHEET 3 A 9 ARG A 579 THR A 584 -1 O TYR A 581 N ILE A 572 SHEET 4 A 9 VAL A 711 HIS A 714 1 O VAL A 713 N ILE A 582 SHEET 5 A 9 GLY A 606 MET A 609 1 N VAL A 608 O VAL A 712 SHEET 6 A 9 GLU A 667 TYR A 676 1 O PHE A 674 N VAL A 607 SHEET 7 A 9 TYR A 653 ASN A 662 -1 N ARG A 656 O HIS A 673 SHEET 8 A 9 LEU A 640 ILE A 649 -1 N SER A 646 O GLN A 657 SHEET 9 A 9 MET A 633 PHE A 635 -1 N MET A 633 O LEU A 642 SHEET 1 B 8 ALA B1069 MET B1074 0 SHEET 2 B 8 ARG B1079 THR B1084 -1 O TYR B1081 N ILE B1072 SHEET 3 B 8 VAL B1211 HIS B1214 1 O VAL B1213 N ILE B1082 SHEET 4 B 8 GLY B1106 MET B1109 1 N VAL B1108 O VAL B1212 SHEET 5 B 8 THR B1168 TYR B1176 1 O PHE B1174 N VAL B1107 SHEET 6 B 8 TYR B1153 ASN B1162 -1 N ARG B1156 O HIS B1173 SHEET 7 B 8 LEU B1140 ILE B1149 -1 N SER B1146 O GLN B1157 SHEET 8 B 8 MET B1133 PHE B1135 -1 N PHE B1135 O LEU B1140 SITE 1 AC1 3 ARG A 524 ARG A 754 GLN A 762 SITE 1 AC2 18 TYR A 546 ARG A 547 ASP A 548 PHE A 682 SITE 2 AC2 18 CYS A 715 SER A 716 ALA A 717 GLY A 718 SITE 3 AC2 18 ILE A 719 GLY A 720 ARG A 721 MET A 758 SITE 4 AC2 18 GLY A 759 GLN A 762 HOH A3035 ALA B1018 SITE 5 AC2 18 GLN B1021 ARG B1024 SITE 1 AC3 24 ALA A 518 ASP A 522 HIS A 525 GLU A 526 SITE 2 AC3 24 TYR B1020 ARG B1024 TYR B1046 ARG B1047 SITE 3 AC3 24 ASP B1048 LEU B1119 PHE B1182 CYS B1215 SITE 4 AC3 24 SER B1216 ALA B1217 GLY B1218 ILE B1219 SITE 5 AC3 24 GLY B1220 ARG B1221 ARG B1254 MET B1258 SITE 6 AC3 24 GLN B1262 HOH B3081 HOH B3140 HOH B3204 CRYST1 87.945 88.045 139.228 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011371 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011358 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007182 0.00000